SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MedImmune
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
416 47 0 MEDI
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
41 The phase III of MEDI-493 is not "a better application of a new drug"Dr. Bob-5/9/1997
40 Are you talking about the phase III mentioned in the link I posted? And yes, IJames Mortensen-5/8/1997
39 Jim, Isn't the phase III being done - a better application for their approShlepper-5/7/1997
38 Here's the press release for the latest and last of the Phase III clinicalsJames Mortensen-5/6/1997
37 Hi Jim, I think that there are lots of hands in the pie at Medimmune and it wiShlepper-4/25/1997
36 Hey Shlep- Here's the latest press release, with quarterly earnings and saJames Mortensen-4/25/1997
35 I guess that the market in biotechs is flat. The fact that MEDIMMUNE has greatShlepper-4/25/1997
34 Merrill Lynch issued an "accumulate" recommendation for MedImmune todJames Mortensen-4/9/1997
33 My understanding is that today's jump was related to a recommendation by anJames Mortensen-4/9/1997
32 Sorry about the brevity of this mornings post. I was on my way out the door. James Mortensen-4/8/1997
31 Thanks James for the post. I also see there was a press release today. nice movPENNY-4/8/1997
30 washington post news story washingtonpost.comJames Mortensen-4/8/1997
29 The only alternative treatment I'm aware of is Ribavirin, an antiviral drugDr. Bob-4/4/1997
28 Dr Bob, thanks for comments. I would think MEDI 493 would be cheaper to producbill small-4/4/1997
27 Bill, Yes, I'm impressed by this company's approach overall. We were Dr. Bob-3/31/1997
26 Dr Bob, some questions for you I am MEDI shareholder and attended last year&bill small-3/31/1997
25 I was curious about what you meant by "conflict of interest." And thJames Mortensen-3/31/1997
24 Penny, these threads are good for getting various viewpoints. People will writeJames Mortensen-3/31/1997
23 Penny and all, The shortage of RespiGam should not be a long term problem if tDr. Bob-3/30/1997
22 Doug, I really haven't been involved with stocks for that long that is proPENNY-3/30/1997
21 No, a limited supply in the face of increased demand will be a negative for MedDoug Meetmer-3/30/1997
20 An interesting point. My experience leads me to believe that generally, when aDoug Meetmer-3/30/1997
19 I understand your point about the blind study. The research team is excited bePENNY-3/30/1997
18 Robert, Your assessment is correct. I have a couple family members who have James Mortensen-3/30/1997
17 Doug, I think you've misinterpreted the RespiGam shortage - it has more toDr. Bob-3/30/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News